TOBI (The Orthobiologic Institute) Faculty Present Large Randomized Trial at AAOS (American Academy of Orthopaedic Surgery) Annual Meeting that Confirms Value of Platelet Rich Plasma for Tennis Elbow Patients
TOBI Faculty, Dr. Allan K. Mishra MD, Steven Sampson DO, and David C. Karli MD, MBA participated in the largest study done to date using PRP.
The study was a randomized, double-blind, multi-center controlled trial of 230 patients. Patients received needling of their elbow tendons with and without PRP. At 24 weeks the PRP patients reports a 71.5% improvement in their pain compared to 56.1 in the control group. (P = 0.027) Patients treated with PRP also had less elbow tenderness at each follow up point. Overall, 84% of the PRP patients were successfully treated compared to 68.3% of the control group. (P = 0.012)
84% of patients with chronic tennis elbow who had failed other non-operative treatments were successfully treated using platelet-rich plasma (PRP) in a large randomized trial.
There are now over 340 patients who have been treated with the same system (Biomet GPS PRP) and techniques confirming the value of PRP as a treatment for chronic tennis elbow. Importantly, there is also a decade long experience using PRP with an excellent safety profile. PRP with this newly released data can now be confidently used for chronic tennis elbow patients prior to considering surgical intervention.
The results will be presented by Dr. Allan K. Mishra at TOBI 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Event details and registration online at www.prpseminar.com.
Platelet-Rich Plasma Significantly Improves Clinical Outcomes in Patients with Chronic Tennis Elbow: A Double-Blind, Prospective, Multicenter, Controlled Trial of 230 Patients
Allan K. Mishra, MD; Nebojsa V. Skrepnik, MD, PhD; Scott G. Edwards, MD; Grant L. Jones, MD; Steven Sampson, DO; Doug A. Vermillion, MD; Matthew L. Ramsey, MD; David C. Karli, MD, MBA; Arthur C. Rettig, MD
For more of the latest PRP research and clinical experience, plus networking with field leaders, attend The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Details and registration at www.prpseminar.com. Early Rates through March 31st – Register Now!